Celularity Inc SEC filings CELU

Celularity Inc has 560 filings in SEC EDGAR's recent list, going back to Nov 5, 2018. Its latest annual report, Form 10-K, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 20, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
PRE 14A Preliminary proxy statement Oct 29, 2026 Oct 28, 2026
DEFA14A Additional proxy material Nov 7, 2025 —
DEF 14A Proxy statement Nov 7, 2025 Nov 7, 2025
DEF 14A Proxy statement Nov 19, 2024 Oct 19, 2024
DEF 14A Proxy statement Feb 2, 2024 Feb 2, 2024
PRE 14A Preliminary proxy statement Jan 23, 2024 Jan 23, 2024
DEF 14A Proxy statement May 1, 2023 Jun 14, 2023
PRE 14A Preliminary proxy statement Apr 21, 2023 Jun 14, 2023
DEF 14A Proxy statement Jun 3, 2022 Jul 13, 2022
DEFA14A Additional proxy material May 10, 2021 —
DEFA14A Additional proxy material Apr 16, 2021 —
DEF 14A Proxy statement Apr 14, 2021 May 14, 2021
PRE 14A Preliminary proxy statement Mar 29, 2021 Mar 29, 2021
DEF 14A Proxy statement Dec 4, 2020 Dec 29, 2020

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CELU (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Florham Park, NJ
SEC filer status
, Emerging growth company
SEC CIK
1752828
Former names
GX Acquisition Corp. (until Jul 19, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.